Resources and population served: a description of the Ontario Paediatric Diabetes Network
Background: The Network of Ontario Pediatric Diabetes Programs was established in 2001
to provide access to specialized pediatric diabetes care. Universal funding for pediatric …
to provide access to specialized pediatric diabetes care. Universal funding for pediatric …
[PDF][PDF] Pediatric insulin pump therapy: reflecting on the first 10 years of a universal funding program in Ontario
We evaluated the universal funding program for pediatric insulin pumps in Ontario by
examining the dynamics underlying patterns of pump use and adverse events using …
examining the dynamics underlying patterns of pump use and adverse events using …
Insulin pump use and discontinuation in children and teens: a population‐based cohort study in Ontario, Canada
Objective To describe insulin pump use by youth since introduction of universal funding in
Ontario, Canada and to explore the relationship between pump use and pediatric diabetes …
Ontario, Canada and to explore the relationship between pump use and pediatric diabetes …
Home insulin pump use in hospitalized children with type 1 diabetes
J Owens, J Courter, CL Schuler, M Lawrence… - JAMA Network …, 2024 - jamanetwork.com
Importance Pediatric data on inpatient home insulin pumps are absent in the literature.
Understanding safety of home insulin pumps, managed by patients or caregivers, during …
Understanding safety of home insulin pumps, managed by patients or caregivers, during …
Low socioeconomic status is associated with adverse events in children and teens on insulin pumps under a universal access program: a population-based cohort …
Objective To describe adverse events in pediatric insulin pump users since universal
funding in Ontario and to explore the role of socioeconomic status and 24-hour support …
funding in Ontario and to explore the role of socioeconomic status and 24-hour support …
Insulin pump use in children with type 1 diabetes: over a decade of disparities
TH Lipman, SM Willi, CW Lai, JA Smith, O Patil… - Journal of pediatric …, 2020 - Elsevier
Purpose Racial disparities have been shown in outcomes and treatment of children with
type 1 diabetes (T1D). The purpose of this study was to examine temporal trends in insulin …
type 1 diabetes (T1D). The purpose of this study was to examine temporal trends in insulin …
Insulin pump therapy in children with type 1 diabetes: analysis of data from the SWEET registry
A Szypowska, A Schwandt, J Svensson… - Pediatric …, 2016 - Wiley Online Library
Background Intensified insulin delivery using multiple daily injections (MDI) or continuous
subcutaneous insulin infusion (CSII) is recommended in children with type 1 diabetes (T1D) …
subcutaneous insulin infusion (CSII) is recommended in children with type 1 diabetes (T1D) …
Comparison of socioeconomic disparities in pump uptake among children with type 1 diabetes in 2 Canadian provinces with different payment models
JM Ladd, A Sharma, E Rahme, K Kroeker… - JAMA network …, 2022 - jamanetwork.com
Importance Insulin pumps improve glycemic control and quality of life in children with type 1
diabetes (T1D). Canada's provinces have implemented universal pediatric programs to …
diabetes (T1D). Canada's provinces have implemented universal pediatric programs to …
Valuing technology: a qualitative interview study with physicians about insulin pump therapy for children with type 1 diabetes
Insulin pumps for children with type 1 diabetes have been broadly adopted despite
equivocal evidence about comparative effectiveness. To understand why and inform policy …
equivocal evidence about comparative effectiveness. To understand why and inform policy …
[HTML][HTML] Benchmarking diabetes technology use among 21 US pediatric diabetes centers
P Prahalad, H Hardison, O Odugbesan… - Clinical Diabetes: A …, 2024 - ncbi.nlm.nih.gov
Abstract The American Diabetes Association's Standards of Care in Diabetes recommends
the use of diabetes technology such as continuous glucose monitoring systems and insulin …
the use of diabetes technology such as continuous glucose monitoring systems and insulin …